Long Position on INMD @ $35.50 on 12/20/2022 (Momentum)

InMode Ltd. (INMD) designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. 

The company offers minimally-invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments.

It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation.

InMode Ltd. offers its products directly in United States, Canada, United Kingdom, Spain, India, Australia, and France, as well as through distributors in 47 countries. 

Shares are heading higher in an upward trading channel. The lower boundary of the channel coincides with the stock's 50-day moving average.

Entry Point: $35.50

Trading Range: $20.60 to $73.75

Stop Loss: $33.75

Target Price: $39.10

Position closed on 1/12/2023 at price of $33.75 with a -4.93% loss in 22 days.

Back to Portfolio